Literature DB >> 19353811

The spectrum of 5-fluorouracil cardiotoxicity.

Jonathan R Dalzell1, Leslie M Samuel.   

Abstract

Cardiotoxicity is a rare but serious complication of 5-fluorouracil therapy. Coronary vasospasm and, less frequently, acute myocarditis have been identified as underlying mechanisms. We report a case of severe toxicity in a relatively young and fit male patient being treated for metastatic colonic adenocarcinoma displaying characteristics that cannot be explained by either mechanism alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353811     DOI: 10.1097/cad.0b013e3283165f27

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  10 in total

Review 1.  Cardiovascular complications of metastatic colorectal cancer treatment.

Authors:  Kalliopi Keramida; Georgios Charalampopoulos; Dimitrios Filippiadis; Elias Tsougos; Dimitrios Farmakis
Journal:  J Gastrointest Oncol       Date:  2019-08

2.  Rapid Extracorporeal Membrane Oxygenation Overcomes Fulminant Myocarditis Induced by 5‑Fluorouracil.

Authors:  Alok R Amraotkar; Ajay Pachika; Kendra J Grubb; Andrew P DeFilippis
Journal:  Tex Heart Inst J       Date:  2016-04-01

3.  Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity.

Authors:  Michael G Fradley; Conor D Barrett; John R Clark; Sanjeev A Francis
Journal:  Tex Heart Inst J       Date:  2013

4.  Takotsubo cardiomyopathy caused by infusion reaction to trastuzumab.

Authors:  Toshihiko Matsumoto; Takashi Oda; Yu Yoshida; Shogo Kimura; Hitomi Himei; Takao Tsuduki; Shinjiro Takagi; Masahiro Takatani; Hirofumi Morishita
Journal:  Int Cancer Conf J       Date:  2019-12-06

5.  Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?

Authors:  Jun Chong; Andrew Fw Ho; Jonathan Yap; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Cond Med       Date:  2019-10

6.  Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.

Authors:  Matteo Coen; Fabio Rigamonti; Arnaud Roth; Thibaud Koessler
Journal:  BMC Cancer       Date:  2017-06-02       Impact factor: 4.430

7.  Possible mechanism for disposal of degenerative cardiomyocytes in human failing hearts: phagocytosis by a neighbour.

Authors:  Genzou Takemura; Kenji Onoue; Tomoya Nakano; Takuya Nakamura; Yasuhiro Sakaguchi; Akiko Tsujimoto; Nagisa Miyazaki; Takatomo Watanabe; Hiromitsu Kanamori; Hideshi Okada; Masanori Kawasaki; Takako Fujiwara; Hisayoshi Fujiwara; Yoshihiko Saito
Journal:  ESC Heart Fail       Date:  2018-11-27

Review 8.  Takotsubo cardiomyopathy in cancer patients.

Authors:  Aakash Desai; Arish Noor; Saurabh Joshi; Agnes S Kim
Journal:  Cardiooncology       Date:  2019-07-01

9.  What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review.

Authors:  Aneta Aleksova; Giulia Gagno; Alessandro Pierri; Carla Todaro; Alessandra Lucia Fluca; Valentina Orlando; Alessandra Guglielmi; Antonio Paolo Beltrami; Gianfranco Sinagra
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-12

Review 10.  5-FU induced cardiotoxicity: case series and review of the literature.

Authors:  Cai Yuan; Hiral Parekh; Carmen Allegra; Thomas J George; Jason S Starr
Journal:  Cardiooncology       Date:  2019-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.